StonvexLoading…
StonvexStonvexStonvexCore line items from DOW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $9.79B | $39.97B | $30.51B | $20.54B |
Operating Income | $-390.00M | $-2.51B | $-963.00M | $-1.03B |
Net Income | $-533.00M | $-2.44B | $-1.08B | $-1.14B |
EPS (Diluted) | $-0.74 | $-3.70 | $-1.53 | $-1.62 |
Total Assets | $59.78B | $58.54B | $60.99B | $58.99B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $4.11B | $3.82B | $4.61B | $2.40B |
Free Cash Flow OCF − CapEx | $621.00M | $-1.45B | $-1.16B | $-1.73B |
Shares Outstanding | 721.20M | 711.60M | 709.40M | 708.20M |